Haematological biomarkers of pathological response on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA non-small cell lung cancer (NSCLC) patients.

被引：0

作者：

Laza Briviesca, Raquel

Cruz Bermudez, Alberto

Barquin, Miguel

Nadal, Ernest

Insa, Amelia

Garcia-Campelo, Rosario

De Dios Alvarez, Noemi

Domine, Manuel

Massuti, Bartomeu

Majem, Margarita

Rodriguez-Abreu, Delvys

Martinez Marti, Alex

Cobo, Manuel

Lopez-Vivanco, Guillermo

del Barco, Elvira

Bernabe, Reyes

Vinolas, Nuria

Barneto, Isidoro

Viteri, Santiago

Provencio-Pulla, Mariano

机构：

[1] Hosp Univ Puerta De Hierro Majadahonda, Inst Invest Sanitaria Puerta De Hierro Segovia Ar, Madrid, Sudan

[2] Hosp Univ Puerta de Hierro, Majadahonda, Spain

[3] Inst Catala Oncol, Barcelona, Spain

[4] Hosp Clin Univ Valencia, Valencia, Spain

[5] Univ Hosp A Coruna, Coruna, Spain

[6] Complejo Hosp Univ Vigo, Vigo, Spain

[7] Univ Hosp Fdn Jimenez Diaz, Dept Oncol, Madrid, Spain

[8] Univ Hosp Fdn Jimenez Diaz, Translat Oncol Div, Madrid, Spain

[9] Alicante Univ Hosp ISABIAL, Alicante, Spain

[10] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[11] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain

[12] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[13] Hosp Reg Univ Malaga, Malaga, Spain

[14] Hosp Cruces, Dept Med Oncol, Baracaldo, Spain

[15] Salamanca Univ Hosp, Dept Med Oncol, Salamanca, Spain

[16] Hosp Valme, Seville, Spain

[17] Hosp Clin Barcelona, Barcelona, Spain

[18] Hosp Reina Sofia, Cordoba, Spain

[19] Pangaea Biotech, Clin Unit, Barcelona, Spain

[20] Hosp Univ Puerta de Hierro, Madrid, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20026

引用

页数：2

共 50 条

[21] NEO-ADJUVANT CHEMO/IMMUNOTHERAPY IN THE TREATMENT OF STAGE III (N2) NON-SMALL CELL LUNG CANCER: A PHASE I/II PILOT STUDY
Ratto, G. B.
Costa, R.
Maineri, P.
Alloisio, A.
Piras, M. T.
D'Agostino, A.
Tripodi, G.
Rivabella, L.
Dozin, B.
Bruzzi, P.
Melioli, G.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2011, 24 (04) : 1005 - 1016
[22] Efficacy and biomarker identification of neoadjuvant chemo-immunotherapy in potentially resectable non-small cell lung cancer
Zhang, Y.
Zeng, L.
Zhang, X.
Zhou, Y.
Zhang, B.
Guo, L.
Guan, Y.
Gao, X.
Wang, H.
Xia, X.
Zhou, C.
Yang, N.
ANNALS OF ONCOLOGY, 2021, 32 : S934 - S934
[23] NEO-ADJUVANT CHEMOTHERAPY AND RADIATION THERAPY IN PATIENTS WITH STAGE IIIA (N2) NON-SMALL CELL LUNG CANCER (NSCLC). A RETROSPECTIVE ANALYSIS WITH LESSONS LEARNED
Friedman, Eliot
Szwerc, Michael
Andrews, Charles
Kruklitis, Robert
Santiago, Ferdy
Leies, Kathleen
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1575 - S1575
[24] The impact of neo-adjuvant treatment on survival in stage III non-small cell lung cancer (NSCLC): Results from the SEER registry
Koshy, M.
Goloubeva, O.
Suntharalingam, M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S465 - S465
[25] Chemo-immunotherapy A new option for non-small cell lung cancer
Vitale, Giovanni
Abbruzzese, Alberto
Tonini, Giuseppe
Santini, Daniele
CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 503 - 504
[26] Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting
de Marinis, Filippo
Ardizzoni, Andrea
Attili, Ilaria
Bonanno, Laura
Bria, Emilio
Cortinovis, Diego Luigi
Margaritora, Stefano
Mazzoni, Francesca
Mercadante, Edoardo
Morabito, Alessandro
Petrella, Francesco
Rea, Federico
Salvi, Rosario
Solli, Piergiorgio
Spaggiari, Lorenzo
Voltolini, Luca
Gridelli, Cesare
CURRENT ONCOLOGY, 2025, 32 (02)
[27] Phase III trials of neo-adjuvant chemotherapy in Stage IIIA non-small cell lung cancer - does size matter?
Krieger, Laurence
Pavlakis, Nick
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (02) : 73 - 75
[28] ERCC1-GENE EXPRESSION AS A RESPONSE PREDICTIVE MARKER TO NEO-ADJUVANT THERAPY WITH CISPLATIN AND DOCETAXEL IN STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER (NSCLC)
Buffoni, Lucio
Ruffini, Enrico
Filippi, Andrea Riccardo
Consito, Lorena T.
Mantovani, Cristina
Bironzo, Paolo
Paze, Enrica
Birocco, Nadia
Milanesi, Enrica
Oliaro, Alberto
Ricardi, Umberto
Schena, Marina
Ciuffreda, L.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1073 - S1074
[29] Stage IIIA Non-Small Cell Lung Cancer (NSCLC): Outcomes by Treatment Strategy
Carroway, W. P.
Jiang, S-F.
Velotta, J.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S588 - S589
[30] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
Rocco, Danilo
Della Gravara, Luigi
Battiloro, Ciro
Gridelli, Cesare
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568

← 1 2 3 4 5 →